CUDC-101

Overview

CUDC-101 is a small-molecule inhibitor that targets histone deacetylases (HDACs), epidermal growth factor receptor tyrosine kinase (EGFR/ErbB1), and human epidermal growth factor receptor 2 tyrosine kinase (HER2/ErbB2). As a hybrid dual-acting inhibitor, it not only blocks these receptors but also reduces compensatory pathways such as AKT, HER3, and MET. CUDC-101 shows potential in suppressing various tumor progressions. Reagent-grade; for laboratory research purposes only.

Application

Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API

Product Information

• Catalog No.: BP-40066
• CAS No.: 1012054-59-9
• Molecular Formula: C24H26N4O4
• Molecular Weight: 434.5
• Storage: -20°C
• Availability: 24 Hours

Source

Original product source